Summary Tumours of the head and neck were examined for gene amplification and expression of the epidermal growth factor (EGF) receptor by Southern blot and Western blot analyses. The EGF receptor gene was found to be amplified in four (19%) of 21 squamous cell carcinomas. The EGF receptor was overexpressed in eight (53%) of 15 squamous cell carcinomas examined, including all four tumours showing gene amplification. No amplification or overexpression of the EGF receptor gene was detected in any of nine malignant or eight benign tumours of other types of the head and neck. The tumours showing amplification and/or overexpression of the EGF receptor gene (8/15) were all identified histologically as well differentiated squamous cell carcinomas, whereas none of the histologically less differentiated squamous cell carcinomas (0/9) showed amplification and/or overexpression of the EGF receptor gene. Within our sample set, no correlation was evident between amplification and/or overexpression and the clinical stage or tumour site. Our results support the possible involvement of gene amplification and overexpression of the EGF receptor in a subclass of squamous cell carcinomas of the head and neck.
Several oncogenes have been identified in human tumours and there is accumulating evidence that oncogenes may be involved in different stages of the multi-step carcinogenesis process. For instance, ras oncogenes have been detected at high incidence in various human tumours. The N-myc oncogene has been found in a significant percentage of human neuroblastomas and its incidence has been shown to be well correlated with the clinical stage of these tumours (Pelicci et al., 1984) .
EGF is a polypeptide with potent mitogenic activity that stimulates proliferation of a variety of cells through interaction with its receptor. The EGF receptor is a transmembrane glycoprotein of Mr 170,000 on the surface of many types of cells. From sequence analysis, the EGF receptor gene is suggested to be the proto-oncogene of the erbB oncogene (Yamamoto et al., 1983; Downward et al., 1984) . Therefore, qualitatively and/or quantitatively abnormal expression of the EGF receptor gene may be involved in some stage of carcinogenesis. High levels of EGF receptor expression have been observed in some types of tumours (Gullick et al., 1986; Berger et al., 1987; Ro et al., 1988; Yasui et al., 1988) , sometimes associated with amplification of the EGF receptor gene. There are only a few reports related to oncogenes involved in tumours of the head and neck. Most tumours in these regions are squamous cell carcinomas. Since A431 cells, which were established from a squamous cell carcinoma, express 10-50 times more EGF receptor than do most other cell lines (Merlino et al., 1984) , involvement of the EGF receptor gene in tumours of the head and neck is of particular interest. In fact, amplification of the EGF receptor gene (Yamamoto et al., 1986) and increased EGF receptor (Cowley et al., 1986) were observed in the case of a number of cell lines derived from human squamous cell carcinomas. In addition, Ozanne et al. (1986) DNA isolation and Southern blot hybridisation High molecular weight DNA was prepared from thin slices of frozen tissues as described previously (Wigler et al., 1979) . The DNAs (104g) were cleaved with the restriction endonuclease EcoRI, fractionated on the basis of size by electrophoresis in 1% agarose gel, denatured, neutralised and (Yamamoto et al., 1986) . Examples of autoradiograms of the squamous cell carcinomas are shown in Figure 1 and data on the 21 squamous cell carcinomas examined are summarised in Table II (Figure 2 ). In these cases, the EGF receptor gene was not amplified. T3NOMO  T3N2aMO  T3N2cMO  T2N2MO  T3N1MO  TIbNOMO  T2NOMO  T4NOMO  T2NOMO  T3NOMO  T4NOMO  T3N2aMO  T4N2MI  T2NlMO  T3NOMO  T2NOMO  T2NOMO   III  IV  IV  IV  III  I  II  IV  II  IV  IV  IV  IV  II  IV  II  II   T3N2MO  IV  T3N3MO 
Discussion
There are few published studies of oncogene amplification/ expression in squamous cell carcinomas of the head and neck. Spandidos et al. (1985) examined 14 specimens of squamous cell carcinoma of the head and neck and found that in most cases the expression of the ras and myc oncogenes was elevated but that these genes were not amplified. In another paper (Field et al., 1986) , no correlation was found between elevated expression of these genes and clinical features other than for a significant difference between myc expression in early and in advanced stages of tumour development. Ozanne et al. (1986) (Yasui et al., 1988) . Moreover, the EGF receptor was shown to be overexpressed on cytoplasmic membranes (Ro et al:, 1988 (Ozanne et al., 1986) . However, we also observed overexpression of the receptor in four other squamous cell carcinomas in which no amplification of the gene was detected. This finding indicates that gene amplification is not the only mechanism by which the level of the EGF receptor can be increased, as stated previously (Xu et al., 1984b) .
Of special interest in the study is the observation that all tumours showing amplification and/or overexpression of the EGF receptor were identified histologically as well differentiated squamous cell carcinomas. These results suggested that overexpression of the EGF receptor may be related to differentiation as compared with myc expression (Field et al., 1986) , which is stage-related in squamous cell carcinomas of the head and neck. This finding is similar to a report (Yokota et al., 1988 ) that amplification of erbB-2 is relatively high in the well differentiated type of gastric carcinoma.
Recently, a correlation was observed between invasiveness of human bladder tumours and overexpression of EGF receptor (Neal et al., 1985) , suggesting that examination of this receptor is useful for predicting the prognosis of tumours. There is also a report that advanced gastric carcinomas showed a higher level of expression of the EGF receptor than early gastric carcinomas, but that this correlation was not found in colon carcinomas (Yasui et al., 1988 Southern blot analysis revealed RFLP of the EGF receptor gene in four of the cases tested. This RFLP was detected as an abnormal band of 4.5kbp. Kawashima and Nishimura (personal communication) suggested that this RFLP was closely related to gastric carcinoma and may be an indicator for prediction of the appearance of gastric carcinoma. In contrast, RFLP was not detected in any of the patients with squamous cell carcipioma examined in our present study. These results suggest that RFLP of the EGF receptor gene has no influence on development of squamous cell carcinoma of head and neck. Similarly, no correlation between RFLP of the Ha-ras oncogene and colon adenocarcinoma was found (Nelli et al.; . Interestingly, we observed RFLP in each of the two patients with pleomorphic adenoma. Larger numbers of patients will need to be examined to determine whether this association is significant.
In the present study, we demonstrated high incidences of amplification and/or overexpression of the EGF receptor gene in well differentiated squamous cell carcinomas of the head and neck. However, our results did not indicate the clinical significance of overexpression of the EGF receptor. Further studies are needed to determine whether gene amplification and/or overexpression of the EGF receptor is related to the development or prognosis of these squamous cell carcinomas.
